Sarah E. Flanagan

17.3k citations

249 papers · 10.1k indexed · 2 hit papers · h-index 50

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Diabetes Management and Research
- Diabetes Treatment and Management
Genetics top 0.2%
- Diabetes and associated disorders
- Genetics and Neurodevelopmental Disorders

Papers in

Endocrinology, Diabetes and Metabolism 175
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 137
- Diabetes Management and Research 77
- Diabetes Treatment and Management 14
Surgery 152
- Pancreatic function and diabetes 147

Co-authors: Sian Ellard Andrew T. Hattersley Khalid Hussain Ann‐Marie Patch Emma L. Edghill Elisa De Franco Ritika R. Kapoor Julian Hamilton‐Shield
Journals: Diabetologia (16 papers)Diabetes (15 papers)The Journal of Clinical Endocrinology & Metabolism (14 papers)European Journal of Endocrinology (11 papers)Diabetic Medicine (10 papers)
Partner nations: United Kingdom United States Türkiye

In The Last Decade

Sarah E. Flanagan

239 papers receiving 9.9k citations

Hit Papers

align trajectories log scale

An ingestible bacterial-electronic system to monitor gastrointestinal health 2018 · 433 citations

Peers

Countries citing papers authored by Sarah E. Flanagan

Since Specialization

Citations

This map shows the geographic impact of Sarah E. Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Flanagan more than expected).

Fields of papers citing papers by Sarah E. Flanagan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Flanagan. The network helps show where Sarah E. Flanagan may publish in the future.

Co-authors

The 25 scholars most cited alongside Sarah E. Flanagan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah E. Flanagan Line = papers co-authored together Sarah E. Flanagan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Congenital hyperinsulinism in the Ukraine: a 10-year national study Frontiers in Endocrinology ·Evgenia Globa, 章雄福島, Michael Bau Mortensen, Jayne Houghton, Anne Lerberg Nielsen, Sönke Detlefsen, Sarah E. Flanagan	2024	1
2	Widening the phenotypic spectrum caused by pathogenic PDX1 variants in individuals with neonatal diabetes BMJ Open Diabetes Research & Care ·Nicola Jeffery, Surendra Babu.R, Jayne Houghton, Evgenia Globa, Matthew N. Wakeling, Sarah E. Flanagan, Andrew T. Hattersley, Kashyap Patel, Elisa De Franco	2024	1
3	FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome Journal of Clinical Immunology ·Rebecca C. Wyatt, Sven Olek, Elisa De Franco, 汪洪梅, Kashyap Patel, Jayne Houghton, Steffi Walter, Ronald S. Hafner, Rosa Bacchetta, Andrew T. Hattersley, Sarah E. Flanagan, Matthew B. Johnson	2023	8
4	The Role of ONECUT1 Variants in Monogenic and Type 2 Diabetes Mellitus Diabetes ·Misti Lynn, Kashyap Patel, Thomas W. Laver, B Alawi, Matthew B. Johnson, Matthew N. Wakeling, Robert A. Harris, Andrew T. Hattersley, Sarah E. Flanagan, Michael N. Weedon, Elisa De Franco	2023	8
5	Increased referrals for congenital hyperinsulinism genetic testing in children with trisomy 21 reflects the high burden of non‐genetic risk factors in this group Pediatric Diabetes ·Paul Eaton, Thomas W. Laver, Jayne Houghton, Jonna M. E. Männistö, 文展桑島, Stephen Brearey, Shuqing Bai, Antonia Dastamani, 雷振山, Nuala Murphy, Birgit Rami‐Merhar, Jörg Meinlschmidt, Hanna Huopio, Indraneel Banerjee, Matthew B. Johnson, Sarah E. Flanagan	2022	6
6	Hyperinsulinemic Hypoglycemia Diagnosed in Childhood Can Be Monogenic The Journal of Clinical Endocrinology & Metabolism ·P.J.F.G. Meulendijks, Seema Grover, Jayne Houghton, Paul Eaton, Navoda Atapattu, Matthew B. Johnson, Kashyap Patel, Thomas W. Laver, Sarah E. Flanagan	2022	7
7	Identification of GCK‐ maturity‐onset diabetes of the young in cases of neonatal hyperglycemia: A case series and review of clinical features Pediatric Diabetes ·Alice E. Hughes, Elisa De Franco, Evgenia Globa, Nataliya Zelinska, Dörte Hilgard, Fatmanur Varlik, Andrew T. Hattersley, Sarah E. Flanagan	2021	9
8	Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11\n Europe PMC (PubMed Central) ·Paul Eaton, Daphne Yau, C.Y. Kim, Thomas W. Laver, Jayne Houghton, Beverley M. Shields, Sarah E. Flanagan, Kashyap Patel	2021	7
9	Sex-biased islet β cell dysfunction is caused by the MODY MAFA S64F variant by inducing premature aging and senescence in males Cell Reports ·Emily M. Walker, Jeeyeon Cha, Xin Tong, Min Guo, Jinhua Liu, r. Morgan, Donato Iacovazzo, Franck Mauvais‐Jarvis, Sarah E. Flanagan, Márta Korbonits, John M. Stafford, David A. Jacobson, Roland Stein	2021	30
10	Genetic Testing Access and Results for Patients with Congenital Hyperinsulinism as Conducted through the CHI and University of Exeter Partnership C. Schönfelder, Jayne Houghton, N. G. Zhekulin, Sarah E. Flanagan, Stephanie Joy Mawson	2021	1
11	Founder mutation in the PMM2 promotor causes hyperinsulinemic hypoglycaemia/polycystic kidney disease (HIPKD) Molecular Genetics & Genomic Medicine ·W. H. BERGTOLD, Mehmet Tekman, Sarah E. Flanagan, Lisa M. Guay‐Woodford, Teye Kwesi, Sian Ellard, Robert Kleta, Detlef Böckenhauer, Horia Stanescu, Daniela Iancu	2021	2
12	Two decades since the fetal insulin hypothesis: what have we learned from genetics? Diabetologia ·Alice E. Hughes, Andrew T. Hattersley, Sarah E. Flanagan, Rachel M. Freathy	2021	21
13	Comprehensive screening shows that mutations in the known syndromic genes are rare in infants presenting with hyperinsulinaemic hypoglycaemia Clinical Endocrinology ·Thomas W. Laver, Matthew N. Wakeling, 천윤목, Jayne Houghton, Khalid Hussain, Sian Ellard, Sarah E. Flanagan	2018	7
14	An ingestible bacterial-electronic system to monitor gastrointestinal health Science ·Mark Mimee, Phillip Nadeau, Alison Hayward, Sean Carim, Sarah E. Flanagan, 至纯陈, Joy Collins, Shane McDonnell, Richard Swartwout, Robert J. Citorik, Vladimir Bulović, Róbert Langer, Giovanni Traverso, Anantha P. Chandrakasan, Timothy K. Lu Hit paper breakdown →	2018	433
15	Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis Journal of Pediatric Endocrinology and Metabolism ·R NASIRAEI, Khalid Hussain, Sian Ellard, Sarah E. Flanagan, Vijayalakshmi Bhatia	2018	8
16	Recessively InheritedLRBAMutations Cause Autoimmunity Presenting as Neonatal Diabetes Diabetes ·Matthew B. Johnson, Elisa De Franco, Hana Lango Allen, Ke Z, Nancy Samir Elbarbary, Zeynep Şıklar, Merih Berberoğlu, William W. Pond, Alireza Haghighi, Letian Fu, Irfan Ullah, Saif Al-Yaarubi, Daphne Gardner, Ayla Güven, Sian Ellard, Andrew T. Hattersley, Sarah E. Flanagan	2017	48
17	Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance Nature Communications ·Kashyap Patel, Jarno L. T. Kettunen, Markku Laakso, Alena Stančáková, Thomas W. Laver, Kevin Colclough, Matthew B. Johnson, Marc Abramowicz, Leif Groop, Päivi J. Miettinen, Maggie Shepherd, Sarah E. Flanagan, Sian Ellard, Nobuya Inagaki, Andrew T. Hattersley, (unknown), Miriam Cnop, Michael N. Weedon	2017	87
18	Genetic characteristics, clinical spectrum, and incidence of neonatal diabetes in the Emirate of AbuDhabi, United Arab Emirates American Journal of Medical Genetics Part A ·Asma Deeb, Abdelhadi Habeb, Walid Kaplan, Maša Avakumović, Helga Finter, 徐晓楚, Marie-Anne Gérard, Sarah E. Flanagan, Idran Idran, Sian Ellard	2015	31
19	Congenital hyperinsulinism presenting with different clinical, biochemical and molecular genetic spectra. PubMed ·Enver Şimşek, J.A. Coarasa Perez, Sarah E. Flanagan, Sian Ellard, Khalid Hussain, Sare Kabukçuoğlu	2014	1
20	Recessive mutations in the INS gene; a novel common cause of permanent neonatal diabetes in consanguineous pedigrees Queensland's institutional digital repository (The University of Queensland) ·Raul Lilo, Jonathan M. Locke, Sarah E. Flanagan, Ann‐Marie Patch, Lorna W. Harries, Sian Ellard, Andrew T. Hattersley	2008	2

About Sarah E. Flanagan

Sarah E. Flanagan is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Genetics, Neurology and Clinical Biochemistry, having authored 249 papers that have together received 10.1k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (147 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (137 papers), Diabetes Management and Research (77 papers), Diabetes and associated disorders (61 papers), Metabolism, Diabetes, and Cancer (31 papers), Neuroblastoma Research and Treatments (23 papers), Diabetes Treatment and Management (14 papers) and Pancreatic and Hepatic Oncology Research (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (5.2k citations), Genetics (4.5k citations), Surgery (6.5k citations), Molecular Biology (3.2k citations) and Clinical Biochemistry (259 citations). Sarah E. Flanagan has collaborated with scholars based in United Kingdom, United States and Türkiye. Frequent co-authors include Sian Ellard, Andrew T. Hattersley, Khalid Hussain, Ann‐Marie Patch, Emma L. Edghill, Elisa De Franco, Ritika R. Kapoor, Julian Hamilton‐Shield, Jayne Houghton and Hana Lango Allen. Their work appears in journals such as Diabetologia, Diabetes, The Journal of Clinical Endocrinology & Metabolism, European Journal of Endocrinology and Diabetic Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact